🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Hoth Therapeutics Inc (HOTH)

NASDAQ
Currency in USD
Disclaimer
0.8260
+0.0445(+5.12%)
Closed
After Hours
0.8300+0.0040(+0.4843%)
HOTH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.78000.8398
52 wk Range
0.58001.7300
Prev. Close
0.7815
Open
0.818
Day's Range
0.78-0.8398
52 wk Range
0.58-1.73
Volume
67,073
Average Volume (3m)
3,718,356
1-Year Change
-41.83%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
HOTH Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
4.5000
Upside
+444.7942%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Hoth Therapeutics Inc Company Profile

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer’s or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; and HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.

Employees
3

Compare HOTH to Peers and Sector

Metrics to compare
HOTH
Peers
Sector
Relationship
P/E Ratio
−0.8x−4.1x−0.6x
PEG Ratio
−0.01−0.080.00
Price/Book
0.6x0.6x2.6x
Price / LTM Sales
-3.6x3.2x
Upside (Analyst Target)
444.8%313.5%44.4%
Fair Value Upside
Unlock12.2%6.2%Unlock

FAQ

What Is the Hoth Therapeutics (HOTH) Stock Price Today?

The Hoth Therapeutics stock price today is 0.826

What Stock Exchange Does Hoth Therapeutics Trade On?

Hoth Therapeutics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Hoth Therapeutics?

The stock symbol for Hoth Therapeutics is "HOTH."

What Is the Hoth Therapeutics Market Cap?

As of today, Hoth Therapeutics market cap is 5.70M.

What is Hoth Therapeutics Earnings Per Share?

The Hoth Therapeutics EPS is -1.56.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.